Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.59
-0.47 (-4.67%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Hold" and an average price target of $22.75. The average 1-year stock price forecast is 137.23% higher than the current stock price, while the lowest is $2.00 (-79.14%) and the highest is $54 (+463.09%).
Price Target: $22.75 (+137.23%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 8 | 0 | 2 |
| Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 10 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Hold Maintains $7 | Hold | Maintains | $7 | -27.01% | Aug 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Upgrades $54 | Buy | Upgrades | $54 | +463.09% | Aug 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 24, 2026 |
| Maxim Group | Maxim Group | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 15, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 | Hold | Maintains | $2 | -79.14% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
15.83M
Revenue Next Year
48.89M
from 15.83M
Increased by 208.93%
EPS This Year
-2.28
from -2.26
EPS Next Year
-1.59
from -2.28
EPS and Forward PE are based on non-GAAP adjusted numbers.